# Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)

> **NCT05082142** · PHASE4 · COMPLETED · sponsor: **Northwestern University** · enrollment: 110 (actual)

## Conditions studied

- Kidney Calculi
- Urologic Diseases
- Benign Prostatic Hypertrophy

## Interventions

- **DRUG:** Tranexamic acid

## Key facts

- **NCT ID:** NCT05082142
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-17
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-12-14
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2024-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05082142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05082142, "Tranexamic Acid to Improve Same-day Discharge Rates After Holmium Laser Enucleation of the Prostate (HoLEP)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT05082142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*